Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs MRNA✓SelectedUSD · MRNAQBTS vs MRNA performance historyLatest closeAs of-4.83%11/18
Stock and ETF performance explorer

QBTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-24.2%
MRNA return
+23.2%
Excess return
-47.5%
Maximum drawdown
-96.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.8%-4.8%0.0%-4.3%
7D-27.8%-20.9%-6.9%-25.8%
30D-35.0%-13.3%-21.7%-33.9%
3M-60.6%+212.6%-273.2%-68.2%
6M-59.7%+309.0%-368.7%-69.5%
YTD-70.6%+567.3%-637.9%-79.9%
1Y-66.5%+689.7%-756.2%-77.8%
3Y+795.2%+157.4%+637.8%+569.3%
5Y-21.9%-21.7%-0.2%-39.3%
All-24.2%+23.2%-47.5%-42.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling